Iceland· IS-IS/1/23/038/01
Soltamcin
A tamsulosin und solifenacin product containing tamsulosinum inn hýdróklóríð,solifenacinum inn súkkínat, registered in Iceland by Williams & Halls ehf.. The same ATC class is registered in 9 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Tamsulosin und solifenacin is registered in 9 of 19 countries.
Countries holding a registration under ATC G04CA53 (tamsulosin und solifenacin), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 6 of them publish a price we can compare per daily dose
Tamsulosin und solifenacin · ATC G04CA53
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Tamsulosinum INN hýdróklóríð,Solifenacinum INN súkkínat
- Manufacturer
- Williams & Halls ehf.
- Country
- Iceland (IS)
- ATC code
- G04CA53
- ATC class
- Tamsulosin und Solifenacin
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 2
2 priced- ean41065530 stk x1 þpakkiISK 9571
- ean52551690 stk x1 þpakkiISK 19539
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under G04CA53
Tamsulosin und solifenacin, as other registers publish it.
- PolandBeplasot+pharma arzneimittel GmbH
- CzechiaBEPLASOT+pharma arzneimittel gmbh, Graz
- CzechiaBEPLASOT+pharma arzneimittel gmbh, Graz
- CzechiaBEPLASOT+pharma arzneimittel gmbh, Graz
- CzechiaBEPLASOT+pharma arzneimittel gmbh, Graz
- CzechiaBEPLASOT+pharma arzneimittel gmbh, Graz
- CzechiaBEPLASOT+pharma arzneimittel gmbh, Graz
- CzechiaBEPLASOT+pharma arzneimittel gmbh, Graz
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c4679093-59c9-41c5-b901-00487047957d GET /v1/drugs/c4679093-59c9-41c5-b901-00487047957d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tafla með breyttan losunarhraða",
"source": "lyfjastofnun",
"atc_raw": "G04CA53",
"marketed": true,
"strength": "6 mg/0,4 mg",
"ma_number": "IS/1/23/038/01",
"substance": "Tamsulosinum INN hýdróklóríð,Solifenacinum INN súkkínat",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt",
"ma_issued_serial": "45100"
}See everything about tamsulosin und solifenacin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.